Specializes in process and analytical development, scale-up and the manufacture of advanced intermediates, regulatory starting materials, and APIs, under GMP and non-GMP conditions. Accelerates the launch of new drugs, providing one-stop CMC services for the full lifecycle of drug development.

Services provided: laboratory-scale synthesis, custom synthesis on laboratory and kilo or pilot scales, process and analytical method development, ICH stability studies, GMP and non-GMP manufacturing of advanced intermediates, regulatory starting materials and APIs to support pre-clinical (APIs for non-GLP/GLP Tox studies for IND enabling studies) and for clinical development through to commercial.

Hande has an international, professional and cohesive team dedicated to R&D (process and analytical) and facilities comprising a 5,000 m² R&D site,a 35,000 m² plant that meets the requirement of NMPA and FDA .

Since established, Hande insists on customer first and service foremost, as will be widely appreciated by our clients, past and present. Hande was awarded the best CDMO service member in the world for the past several years by one of our large clients.